nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—ABCB1—Ezetimibe—atherosclerosis	0.0734	0.152	CbGbCtD
Lomitapide—ABCB1—Simvastatin—atherosclerosis	0.0682	0.141	CbGbCtD
Lomitapide—ABCB1—Lovastatin—atherosclerosis	0.0668	0.138	CbGbCtD
Lomitapide—ABCB1—Pravastatin—atherosclerosis	0.0668	0.138	CbGbCtD
Lomitapide—CYP3A4—Rosuvastatin—atherosclerosis	0.044	0.0909	CbGbCtD
Lomitapide—CYP3A4—Ezetimibe—atherosclerosis	0.044	0.0909	CbGbCtD
Lomitapide—CYP3A4—Simvastatin—atherosclerosis	0.0409	0.0845	CbGbCtD
Lomitapide—CYP3A4—Pravastatin—atherosclerosis	0.04	0.0827	CbGbCtD
Lomitapide—CYP3A4—Lovastatin—atherosclerosis	0.04	0.0827	CbGbCtD
Lomitapide—Xanthoma—Niacin—atherosclerosis	0.0197	0.0961	CcSEcCtD
Lomitapide—Regurgitation—Lovastatin—atherosclerosis	0.00677	0.033	CcSEcCtD
Lomitapide—MTTP—blood vessel—atherosclerosis	0.00641	0.515	CbGeAlD
Lomitapide—Regurgitation—Simvastatin—atherosclerosis	0.00633	0.0309	CcSEcCtD
Lomitapide—Musculoskeletal disorder—Rosuvastatin—atherosclerosis	0.00546	0.0266	CcSEcCtD
Lomitapide—Musculoskeletal disorder—Simvastatin—atherosclerosis	0.00433	0.0211	CcSEcCtD
Lomitapide—MTTP—cardiovascular system—atherosclerosis	0.00286	0.23	CbGeAlD
Lomitapide—Transaminases increased—Lovastatin—atherosclerosis	0.00272	0.0133	CcSEcCtD
Lomitapide—Transaminases increased—Ezetimibe—atherosclerosis	0.00266	0.013	CcSEcCtD
Lomitapide—Transaminases increased—Simvastatin—atherosclerosis	0.00254	0.0124	CcSEcCtD
Lomitapide—Fexofenadine—HRH1—atherosclerosis	0.00231	0.601	CrCbGaD
Lomitapide—Transaminases increased—Pravastatin—atherosclerosis	0.0023	0.0112	CcSEcCtD
Lomitapide—Drug interaction—Rosuvastatin—atherosclerosis	0.0021	0.0103	CcSEcCtD
Lomitapide—Hepatic enzyme increased—Rosuvastatin—atherosclerosis	0.00206	0.0101	CcSEcCtD
Lomitapide—Hepatomegaly—Niacin—atherosclerosis	0.002	0.00978	CcSEcCtD
Lomitapide—Gamma-glutamyltransferase increased—Ezetimibe—atherosclerosis	0.00197	0.00961	CcSEcCtD
Lomitapide—Hepatotoxicity—Niacin—atherosclerosis	0.00184	0.00897	CcSEcCtD
Lomitapide—Gastrooesophageal reflux disease—Ezetimibe—atherosclerosis	0.00179	0.00875	CcSEcCtD
Lomitapide—MTTP—liver—atherosclerosis	0.00177	0.142	CbGeAlD
Lomitapide—Drug interaction—Ezetimibe—atherosclerosis	0.00175	0.00852	CcSEcCtD
Lomitapide—Gamma-glutamyltransferase increased—Pravastatin—atherosclerosis	0.0017	0.00829	CcSEcCtD
Lomitapide—Drug interaction—Simvastatin—atherosclerosis	0.00167	0.00813	CcSEcCtD
Lomitapide—Gastroenteritis—Rosuvastatin—atherosclerosis	0.0016	0.00779	CcSEcCtD
Lomitapide—Antrafenine—PTGS2—atherosclerosis	0.00153	0.399	CrCbGaD
Lomitapide—Drug interaction—Pravastatin—atherosclerosis	0.00151	0.00735	CcSEcCtD
Lomitapide—Muscle twitching—Niacin—atherosclerosis	0.00144	0.00705	CcSEcCtD
Lomitapide—Eructation—Niacin—atherosclerosis	0.00139	0.0068	CcSEcCtD
Lomitapide—Blood alkaline phosphatase increased—Lovastatin—atherosclerosis	0.00138	0.00673	CcSEcCtD
Lomitapide—Blood alkaline phosphatase increased—Ezetimibe—atherosclerosis	0.00135	0.0066	CcSEcCtD
Lomitapide—Blood alkaline phosphatase increased—Simvastatin—atherosclerosis	0.00129	0.00629	CcSEcCtD
Lomitapide—Influenza—Rosuvastatin—atherosclerosis	0.00122	0.00597	CcSEcCtD
Lomitapide—Pain in extremity—Lovastatin—atherosclerosis	0.0012	0.00585	CcSEcCtD
Lomitapide—Pain in extremity—Ezetimibe—atherosclerosis	0.00118	0.00574	CcSEcCtD
Lomitapide—Blood alkaline phosphatase increased—Pravastatin—atherosclerosis	0.00117	0.00569	CcSEcCtD
Lomitapide—Liver function test abnormal—Ezetimibe—atherosclerosis	0.00109	0.0053	CcSEcCtD
Lomitapide—Dermatitis bullous—Niacin—atherosclerosis	0.00108	0.00526	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.00106	0.00517	CcSEcCtD
Lomitapide—Nasopharyngitis—Ezetimibe—atherosclerosis	0.00105	0.00513	CcSEcCtD
Lomitapide—Gastritis—Ezetimibe—atherosclerosis	0.00104	0.00508	CcSEcCtD
Lomitapide—Haematuria—Rosuvastatin—atherosclerosis	0.00104	0.00507	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.00104	0.00506	CcSEcCtD
Lomitapide—Influenza—Lovastatin—atherosclerosis	0.00104	0.00506	CcSEcCtD
Lomitapide—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00103	0.00503	CcSEcCtD
Lomitapide—Sinusitis—Rosuvastatin—atherosclerosis	0.00102	0.00499	CcSEcCtD
Lomitapide—Influenza—Ezetimibe—atherosclerosis	0.00102	0.00496	CcSEcCtD
Lomitapide—Migraine—Niacin—atherosclerosis	0.00101	0.00495	CcSEcCtD
Lomitapide—Abdominal discomfort—Lovastatin—atherosclerosis	0.000993	0.00485	CcSEcCtD
Lomitapide—Gastritis—Simvastatin—atherosclerosis	0.000993	0.00484	CcSEcCtD
Lomitapide—Liver function test abnormal—Niacin—atherosclerosis	0.000951	0.00464	CcSEcCtD
Lomitapide—Dry skin—Niacin—atherosclerosis	0.000944	0.00461	CcSEcCtD
Lomitapide—Liver function test abnormal—Pravastatin—atherosclerosis	0.000936	0.00457	CcSEcCtD
Lomitapide—Dry skin—Pravastatin—atherosclerosis	0.000929	0.00454	CcSEcCtD
Lomitapide—Abdominal discomfort—Simvastatin—atherosclerosis	0.000929	0.00454	CcSEcCtD
Lomitapide—Nasopharyngitis—Pravastatin—atherosclerosis	0.000907	0.00443	CcSEcCtD
Lomitapide—Infestation NOS—Ezetimibe—atherosclerosis	0.000906	0.00442	CcSEcCtD
Lomitapide—Infestation—Ezetimibe—atherosclerosis	0.000906	0.00442	CcSEcCtD
Lomitapide—Abdominal distension—Niacin—atherosclerosis	0.000896	0.00437	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.000894	0.00436	CcSEcCtD
Lomitapide—Influenza—Niacin—atherosclerosis	0.00089	0.00434	CcSEcCtD
Lomitapide—Abdominal distension—Pravastatin—atherosclerosis	0.000882	0.00431	CcSEcCtD
Lomitapide—Influenza—Pravastatin—atherosclerosis	0.000876	0.00428	CcSEcCtD
Lomitapide—Angina pectoris—Niacin—atherosclerosis	0.000867	0.00423	CcSEcCtD
Lomitapide—Sinusitis—Lovastatin—atherosclerosis	0.000867	0.00423	CcSEcCtD
Lomitapide—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000857	0.00418	CcSEcCtD
Lomitapide—Angina pectoris—Pravastatin—atherosclerosis	0.000854	0.00417	CcSEcCtD
Lomitapide—Sinusitis—Ezetimibe—atherosclerosis	0.00085	0.00415	CcSEcCtD
Lomitapide—Flatulence—Rosuvastatin—atherosclerosis	0.00084	0.0041	CcSEcCtD
Lomitapide—Sinusitis—Simvastatin—atherosclerosis	0.000811	0.00396	CcSEcCtD
Lomitapide—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000799	0.0039	CcSEcCtD
Lomitapide—Weight decreased—Pravastatin—atherosclerosis	0.000793	0.00387	CcSEcCtD
Lomitapide—Chills—Lovastatin—atherosclerosis	0.000744	0.00363	CcSEcCtD
Lomitapide—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000733	0.00358	CcSEcCtD
Lomitapide—Sinusitis—Pravastatin—atherosclerosis	0.000733	0.00358	CcSEcCtD
Lomitapide—Myalgia—Rosuvastatin—atherosclerosis	0.000725	0.00354	CcSEcCtD
Lomitapide—Arthralgia—Rosuvastatin—atherosclerosis	0.000725	0.00354	CcSEcCtD
Lomitapide—Flatulence—Lovastatin—atherosclerosis	0.000712	0.00347	CcSEcCtD
Lomitapide—Malnutrition—Ezetimibe—atherosclerosis	0.000708	0.00346	CcSEcCtD
Lomitapide—Back pain—Lovastatin—atherosclerosis	0.000698	0.00341	CcSEcCtD
Lomitapide—Flatulence—Ezetimibe—atherosclerosis	0.000698	0.00341	CcSEcCtD
Lomitapide—Chills—Simvastatin—atherosclerosis	0.000696	0.0034	CcSEcCtD
Lomitapide—Muscle spasms—Lovastatin—atherosclerosis	0.000694	0.00339	CcSEcCtD
Lomitapide—Infection—Rosuvastatin—atherosclerosis	0.000691	0.00337	CcSEcCtD
Lomitapide—Back pain—Ezetimibe—atherosclerosis	0.000685	0.00334	CcSEcCtD
Lomitapide—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000682	0.00333	CcSEcCtD
Lomitapide—Muscle spasms—Ezetimibe—atherosclerosis	0.000681	0.00332	CcSEcCtD
Lomitapide—Ill-defined disorder—Lovastatin—atherosclerosis	0.00067	0.00327	CcSEcCtD
Lomitapide—Eye disorder—Niacin—atherosclerosis	0.000666	0.00325	CcSEcCtD
Lomitapide—Flatulence—Simvastatin—atherosclerosis	0.000666	0.00325	CcSEcCtD
Lomitapide—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000657	0.00321	CcSEcCtD
Lomitapide—Anaemia—Ezetimibe—atherosclerosis	0.000655	0.0032	CcSEcCtD
Lomitapide—Malaise—Lovastatin—atherosclerosis	0.000651	0.00318	CcSEcCtD
Lomitapide—Cardiac disorder—Pravastatin—atherosclerosis	0.000651	0.00318	CcSEcCtD
Lomitapide—Muscle spasms—Simvastatin—atherosclerosis	0.000649	0.00317	CcSEcCtD
Lomitapide—Vertigo—Lovastatin—atherosclerosis	0.000649	0.00317	CcSEcCtD
Lomitapide—Chills—Niacin—atherosclerosis	0.000639	0.00312	CcSEcCtD
Lomitapide—Malaise—Ezetimibe—atherosclerosis	0.000639	0.00312	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000634	0.00309	CcSEcCtD
Lomitapide—Chills—Pravastatin—atherosclerosis	0.000629	0.00307	CcSEcCtD
Lomitapide—Ill-defined disorder—Simvastatin—atherosclerosis	0.000627	0.00306	CcSEcCtD
Lomitapide—Palpitations—Ezetimibe—atherosclerosis	0.000626	0.00305	CcSEcCtD
Lomitapide—Paraesthesia—Rosuvastatin—atherosclerosis	0.000624	0.00305	CcSEcCtD
Lomitapide—Anaemia—Simvastatin—atherosclerosis	0.000624	0.00305	CcSEcCtD
Lomitapide—Malnutrition—Niacin—atherosclerosis	0.00062	0.00303	CcSEcCtD
Lomitapide—Myalgia—Lovastatin—atherosclerosis	0.000615	0.003	CcSEcCtD
Lomitapide—Chest pain—Lovastatin—atherosclerosis	0.000615	0.003	CcSEcCtD
Lomitapide—Arthralgia—Lovastatin—atherosclerosis	0.000615	0.003	CcSEcCtD
Lomitapide—Dyspepsia—Rosuvastatin—atherosclerosis	0.000612	0.00299	CcSEcCtD
Lomitapide—Flatulence—Niacin—atherosclerosis	0.000611	0.00298	CcSEcCtD
Lomitapide—Malaise—Simvastatin—atherosclerosis	0.000609	0.00297	CcSEcCtD
Lomitapide—Discomfort—Lovastatin—atherosclerosis	0.000607	0.00296	CcSEcCtD
Lomitapide—Vertigo—Simvastatin—atherosclerosis	0.000607	0.00296	CcSEcCtD
Lomitapide—Arthralgia—Ezetimibe—atherosclerosis	0.000603	0.00294	CcSEcCtD
Lomitapide—Chest pain—Ezetimibe—atherosclerosis	0.000603	0.00294	CcSEcCtD
Lomitapide—Myalgia—Ezetimibe—atherosclerosis	0.000603	0.00294	CcSEcCtD
Lomitapide—Flatulence—Pravastatin—atherosclerosis	0.000602	0.00294	CcSEcCtD
Lomitapide—Dry mouth—Lovastatin—atherosclerosis	0.000601	0.00293	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000599	0.00292	CcSEcCtD
Lomitapide—Muscle spasms—Niacin—atherosclerosis	0.000596	0.00291	CcSEcCtD
Lomitapide—Discomfort—Ezetimibe—atherosclerosis	0.000596	0.00291	CcSEcCtD
Lomitapide—Constipation—Rosuvastatin—atherosclerosis	0.000595	0.0029	CcSEcCtD
Lomitapide—Dry mouth—Ezetimibe—atherosclerosis	0.00059	0.00288	CcSEcCtD
Lomitapide—Muscle spasms—Pravastatin—atherosclerosis	0.000587	0.00287	CcSEcCtD
Lomitapide—Infection—Lovastatin—atherosclerosis	0.000585	0.00286	CcSEcCtD
Lomitapide—Arthralgia—Simvastatin—atherosclerosis	0.000575	0.00281	CcSEcCtD
Lomitapide—Chest pain—Simvastatin—atherosclerosis	0.000575	0.00281	CcSEcCtD
Lomitapide—Myalgia—Simvastatin—atherosclerosis	0.000575	0.00281	CcSEcCtD
Lomitapide—Infection—Ezetimibe—atherosclerosis	0.000574	0.0028	CcSEcCtD
Lomitapide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000573	0.0028	CcSEcCtD
Lomitapide—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000569	0.00278	CcSEcCtD
Lomitapide—Discomfort—Simvastatin—atherosclerosis	0.000568	0.00277	CcSEcCtD
Lomitapide—Nervous system disorder—Ezetimibe—atherosclerosis	0.000567	0.00277	CcSEcCtD
Lomitapide—Ill-defined disorder—Pravastatin—atherosclerosis	0.000567	0.00277	CcSEcCtD
Lomitapide—ABCB1—blood vessel—atherosclerosis	0.000566	0.0454	CbGeAlD
Lomitapide—Anaemia—Pravastatin—atherosclerosis	0.000564	0.00275	CcSEcCtD
Lomitapide—Skin disorder—Ezetimibe—atherosclerosis	0.000561	0.00274	CcSEcCtD
Lomitapide—Vertigo—Niacin—atherosclerosis	0.000557	0.00272	CcSEcCtD
Lomitapide—Malaise—Pravastatin—atherosclerosis	0.000551	0.00269	CcSEcCtD
Lomitapide—Abdominal pain—Rosuvastatin—atherosclerosis	0.00055	0.00268	CcSEcCtD
Lomitapide—Vertigo—Pravastatin—atherosclerosis	0.000549	0.00268	CcSEcCtD
Lomitapide—Palpitations—Niacin—atherosclerosis	0.000548	0.00267	CcSEcCtD
Lomitapide—Infection—Simvastatin—atherosclerosis	0.000548	0.00267	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000537	0.00262	CcSEcCtD
Lomitapide—Paraesthesia—Lovastatin—atherosclerosis	0.000529	0.00258	CcSEcCtD
Lomitapide—Arthralgia—Niacin—atherosclerosis	0.000528	0.00258	CcSEcCtD
Lomitapide—Myalgia—Niacin—atherosclerosis	0.000528	0.00258	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000527	0.00257	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000524	0.00256	CcSEcCtD
Lomitapide—Arthralgia—Pravastatin—atherosclerosis	0.00052	0.00254	CcSEcCtD
Lomitapide—Myalgia—Pravastatin—atherosclerosis	0.00052	0.00254	CcSEcCtD
Lomitapide—Chest pain—Pravastatin—atherosclerosis	0.00052	0.00254	CcSEcCtD
Lomitapide—Paraesthesia—Ezetimibe—atherosclerosis	0.000519	0.00253	CcSEcCtD
Lomitapide—Dyspepsia—Lovastatin—atherosclerosis	0.000519	0.00253	CcSEcCtD
Lomitapide—Dry mouth—Niacin—atherosclerosis	0.000516	0.00252	CcSEcCtD
Lomitapide—Discomfort—Pravastatin—atherosclerosis	0.000514	0.00251	CcSEcCtD
Lomitapide—Decreased appetite—Lovastatin—atherosclerosis	0.000512	0.0025	CcSEcCtD
Lomitapide—Dyspepsia—Ezetimibe—atherosclerosis	0.000509	0.00248	CcSEcCtD
Lomitapide—Fatigue—Lovastatin—atherosclerosis	0.000508	0.00248	CcSEcCtD
Lomitapide—Constipation—Lovastatin—atherosclerosis	0.000504	0.00246	CcSEcCtD
Lomitapide—Decreased appetite—Ezetimibe—atherosclerosis	0.000502	0.00245	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000502	0.00245	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000499	0.00244	CcSEcCtD
Lomitapide—Asthenia—Rosuvastatin—atherosclerosis	0.000499	0.00244	CcSEcCtD
Lomitapide—Fatigue—Ezetimibe—atherosclerosis	0.000498	0.00243	CcSEcCtD
Lomitapide—Infection—Pravastatin—atherosclerosis	0.000495	0.00242	CcSEcCtD
Lomitapide—Paraesthesia—Simvastatin—atherosclerosis	0.000495	0.00242	CcSEcCtD
Lomitapide—Constipation—Ezetimibe—atherosclerosis	0.000494	0.00241	CcSEcCtD
Lomitapide—Skin disorder—Niacin—atherosclerosis	0.000492	0.0024	CcSEcCtD
Lomitapide—Hyperhidrosis—Niacin—atherosclerosis	0.000489	0.00239	CcSEcCtD
Lomitapide—Feeling abnormal—Lovastatin—atherosclerosis	0.000486	0.00237	CcSEcCtD
Lomitapide—Dyspepsia—Simvastatin—atherosclerosis	0.000485	0.00237	CcSEcCtD
Lomitapide—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000482	0.00235	CcSEcCtD
Lomitapide—Hyperhidrosis—Pravastatin—atherosclerosis	0.000482	0.00235	CcSEcCtD
Lomitapide—Decreased appetite—Simvastatin—atherosclerosis	0.000479	0.00234	CcSEcCtD
Lomitapide—Feeling abnormal—Ezetimibe—atherosclerosis	0.000476	0.00232	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000476	0.00232	CcSEcCtD
Lomitapide—Diarrhoea—Rosuvastatin—atherosclerosis	0.000476	0.00232	CcSEcCtD
Lomitapide—Fatigue—Simvastatin—atherosclerosis	0.000475	0.00232	CcSEcCtD
Lomitapide—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000473	0.00231	CcSEcCtD
Lomitapide—Constipation—Simvastatin—atherosclerosis	0.000471	0.0023	CcSEcCtD
Lomitapide—Body temperature increased—Lovastatin—atherosclerosis	0.000466	0.00227	CcSEcCtD
Lomitapide—Abdominal pain—Lovastatin—atherosclerosis	0.000466	0.00227	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000461	0.00225	CcSEcCtD
Lomitapide—Dizziness—Rosuvastatin—atherosclerosis	0.00046	0.00224	CcSEcCtD
Lomitapide—Abdominal pain—Ezetimibe—atherosclerosis	0.000457	0.00223	CcSEcCtD
Lomitapide—Body temperature increased—Ezetimibe—atherosclerosis	0.000457	0.00223	CcSEcCtD
Lomitapide—Paraesthesia—Niacin—atherosclerosis	0.000454	0.00222	CcSEcCtD
Lomitapide—Feeling abnormal—Simvastatin—atherosclerosis	0.000454	0.00222	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000454	0.00222	CcSEcCtD
Lomitapide—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000451	0.0022	CcSEcCtD
Lomitapide—Somnolence—Niacin—atherosclerosis	0.00045	0.0022	CcSEcCtD
Lomitapide—Paraesthesia—Pravastatin—atherosclerosis	0.000447	0.00218	CcSEcCtD
Lomitapide—Dyspepsia—Niacin—atherosclerosis	0.000446	0.00217	CcSEcCtD
Lomitapide—Decreased appetite—Niacin—atherosclerosis	0.00044	0.00215	CcSEcCtD
Lomitapide—Dyspepsia—Pravastatin—atherosclerosis	0.000439	0.00214	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Niacin—atherosclerosis	0.000437	0.00213	CcSEcCtD
Lomitapide—Body temperature increased—Simvastatin—atherosclerosis	0.000436	0.00213	CcSEcCtD
Lomitapide—Abdominal pain—Simvastatin—atherosclerosis	0.000436	0.00213	CcSEcCtD
Lomitapide—Headache—Rosuvastatin—atherosclerosis	0.000436	0.00213	CcSEcCtD
Lomitapide—Decreased appetite—Pravastatin—atherosclerosis	0.000433	0.00211	CcSEcCtD
Lomitapide—Fatigue—Pravastatin—atherosclerosis	0.00043	0.0021	CcSEcCtD
Lomitapide—Constipation—Pravastatin—atherosclerosis	0.000426	0.00208	CcSEcCtD
Lomitapide—Asthenia—Lovastatin—atherosclerosis	0.000423	0.00206	CcSEcCtD
Lomitapide—Asthenia—Ezetimibe—atherosclerosis	0.000415	0.00202	CcSEcCtD
Lomitapide—Gastrointestinal pain—Niacin—atherosclerosis	0.000414	0.00202	CcSEcCtD
Lomitapide—Nausea—Rosuvastatin—atherosclerosis	0.000413	0.00202	CcSEcCtD
Lomitapide—Feeling abnormal—Pravastatin—atherosclerosis	0.000411	0.002	CcSEcCtD
Lomitapide—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000408	0.00199	CcSEcCtD
Lomitapide—Diarrhoea—Lovastatin—atherosclerosis	0.000403	0.00197	CcSEcCtD
Lomitapide—Body temperature increased—Niacin—atherosclerosis	0.0004	0.00195	CcSEcCtD
Lomitapide—Abdominal pain—Niacin—atherosclerosis	0.0004	0.00195	CcSEcCtD
Lomitapide—Asthenia—Simvastatin—atherosclerosis	0.000395	0.00193	CcSEcCtD
Lomitapide—Diarrhoea—Ezetimibe—atherosclerosis	0.000395	0.00193	CcSEcCtD
Lomitapide—Body temperature increased—Pravastatin—atherosclerosis	0.000394	0.00192	CcSEcCtD
Lomitapide—Abdominal pain—Pravastatin—atherosclerosis	0.000394	0.00192	CcSEcCtD
Lomitapide—Dizziness—Lovastatin—atherosclerosis	0.00039	0.0019	CcSEcCtD
Lomitapide—Dizziness—Ezetimibe—atherosclerosis	0.000382	0.00187	CcSEcCtD
Lomitapide—Diarrhoea—Simvastatin—atherosclerosis	0.000377	0.00184	CcSEcCtD
Lomitapide—Vomiting—Lovastatin—atherosclerosis	0.000375	0.00183	CcSEcCtD
Lomitapide—Headache—Lovastatin—atherosclerosis	0.000369	0.0018	CcSEcCtD
Lomitapide—Vomiting—Ezetimibe—atherosclerosis	0.000368	0.00179	CcSEcCtD
Lomitapide—Dizziness—Simvastatin—atherosclerosis	0.000365	0.00178	CcSEcCtD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000363	0.00123	CbGpPWpGaD
Lomitapide—Asthenia—Niacin—atherosclerosis	0.000363	0.00177	CcSEcCtD
Lomitapide—Headache—Ezetimibe—atherosclerosis	0.000362	0.00177	CcSEcCtD
Lomitapide—Asthenia—Pravastatin—atherosclerosis	0.000358	0.00175	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000353	0.0012	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000353	0.0012	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000353	0.0012	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000353	0.0012	CbGpPWpGaD
Lomitapide—Vomiting—Simvastatin—atherosclerosis	0.00035	0.00171	CcSEcCtD
Lomitapide—Nausea—Lovastatin—atherosclerosis	0.00035	0.00171	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000349	0.00118	CbGpPWpGaD
Lomitapide—ABCB1—ABC-family proteins mediated transport—ABCG5—atherosclerosis	0.000347	0.00118	CbGpPWpGaD
Lomitapide—Diarrhoea—Niacin—atherosclerosis	0.000346	0.00169	CcSEcCtD
Lomitapide—Headache—Simvastatin—atherosclerosis	0.000345	0.00169	CcSEcCtD
Lomitapide—Nausea—Ezetimibe—atherosclerosis	0.000343	0.00168	CcSEcCtD
Lomitapide—Diarrhoea—Pravastatin—atherosclerosis	0.000341	0.00166	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000337	0.00114	CbGpPWpGaD
Lomitapide—Dizziness—Niacin—atherosclerosis	0.000335	0.00163	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—PPARA—atherosclerosis	0.000331	0.00112	CbGpPWpGaD
Lomitapide—Dizziness—Pravastatin—atherosclerosis	0.00033	0.00161	CcSEcCtD
Lomitapide—Nausea—Simvastatin—atherosclerosis	0.000327	0.0016	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.000323	0.0011	CbGpPWpGaD
Lomitapide—Vomiting—Niacin—atherosclerosis	0.000322	0.00157	CcSEcCtD
Lomitapide—Headache—Niacin—atherosclerosis	0.000317	0.00155	CcSEcCtD
Lomitapide—Vomiting—Pravastatin—atherosclerosis	0.000317	0.00155	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—LEP—atherosclerosis	0.000314	0.00107	CbGpPWpGaD
Lomitapide—Headache—Pravastatin—atherosclerosis	0.000312	0.00152	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000311	0.00105	CbGpPWpGaD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CSF1R—atherosclerosis	0.000308	0.00105	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—LDLRAP1—atherosclerosis	0.000307	0.00104	CbGpPWpGaD
Lomitapide—Nausea—Niacin—atherosclerosis	0.000301	0.00147	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.0003	0.00102	CbGpPWpGaD
Lomitapide—Nausea—Pravastatin—atherosclerosis	0.000296	0.00144	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—NOS2—atherosclerosis	0.000293	0.000994	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PLTP—atherosclerosis	0.000289	0.000979	CbGpPWpGaD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.000285	0.000968	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—PPARG—atherosclerosis	0.000274	0.000929	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000267	0.000907	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000266	0.000902	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000264	0.000896	CbGpPWpGaD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.000259	0.000877	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.000258	0.000875	CbGpPWpGaD
Lomitapide—ABCB1—cardiovascular system—atherosclerosis	0.000252	0.0203	CbGeAlD
Lomitapide—MTTP—Metabolism—LTA4H—atherosclerosis	0.00025	0.000849	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ABCG8—atherosclerosis	0.00025	0.000849	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000247	0.000838	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—SERPINE1—atherosclerosis	0.000247	0.000837	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000233	0.000792	CbGpPWpGaD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000224	0.000759	CbGpPWpGaD
Lomitapide—ABCB1—adipose tissue—atherosclerosis	0.000222	0.0179	CbGeAlD
Lomitapide—CYP3A4—liver—atherosclerosis	0.00022	0.0177	CbGeAlD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000217	0.000735	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000208	0.000706	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ABCG1—atherosclerosis	0.000198	0.000671	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—FABP4—atherosclerosis	0.000186	0.000631	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—LCAT—atherosclerosis	0.000186	0.000631	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—MAPK8—atherosclerosis	0.000184	0.000624	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—APOA4—atherosclerosis	0.000183	0.000619	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CYP7A1—atherosclerosis	0.000179	0.000609	CbGpPWpGaD
Lomitapide—CYP3A4—Estrogen metabolism—GSTM1—atherosclerosis	0.000178	0.000603	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000171	0.00058	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CYP27A1—atherosclerosis	0.000166	0.000563	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.000164	0.000557	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000163	0.000554	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.000162	0.00055	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.000159	0.00054	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—APOA2—atherosclerosis	0.000157	0.000533	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ALOX15—atherosclerosis	0.000157	0.000533	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PLA2G2A—atherosclerosis	0.000157	0.000533	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ALOX5AP—atherosclerosis	0.000157	0.000533	CbGpPWpGaD
Lomitapide—ABCB1—liver—atherosclerosis	0.000156	0.0125	CbGeAlD
Lomitapide—MTTP—Metabolism—ABCG5—atherosclerosis	0.000155	0.000527	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000155	0.000526	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.000152	0.000515	CbGpPWpGaD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.00015	0.00051	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—LPA—atherosclerosis	0.00015	0.000509	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.00015	0.000508	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—BGN—atherosclerosis	0.000145	0.000493	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000144	0.000489	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—APOA5—atherosclerosis	0.000144	0.000488	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.00014	0.000474	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PLA2G1B—atherosclerosis	0.000138	0.000469	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000137	0.000464	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000136	0.00046	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000135	0.000459	CbGpPWpGaD
Lomitapide—ABCB1—ABC-family proteins mediated transport—APOA1—atherosclerosis	0.000135	0.000457	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ALOX5—atherosclerosis	0.000134	0.000453	CbGpPWpGaD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000134	0.000453	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.000133	0.000452	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL17A—atherosclerosis	0.00013	0.000441	CbGpPWpGaD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000124	0.000421	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000123	0.000419	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000123	0.000417	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—NAMPT—atherosclerosis	0.00012	0.000407	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000119	0.000404	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—LIPC—atherosclerosis	0.000119	0.000404	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—APOC3—atherosclerosis	0.000118	0.000402	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—LDLR—atherosclerosis	0.000118	0.000399	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—IL6—atherosclerosis	0.000117	0.000398	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CD40—atherosclerosis	0.000115	0.000391	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CETP—atherosclerosis	0.000115	0.00039	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—SCARB1—atherosclerosis	0.00011	0.000373	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—HMOX1—atherosclerosis	0.000109	0.000371	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000107	0.000364	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—AGTR1—atherosclerosis	0.000105	0.000357	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—HMGCR—atherosclerosis	0.000104	0.000353	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—EDN1—atherosclerosis	0.000103	0.00035	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.37e-05	0.000318	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ABCA1—atherosclerosis	9.26e-05	0.000314	CbGpPWpGaD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	9.26e-05	0.000314	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CD40LG—atherosclerosis	8.83e-05	0.0003	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL10—atherosclerosis	8.83e-05	0.0003	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—LEP—atherosclerosis	8.39e-05	0.000285	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—FASLG—atherosclerosis	8.21e-05	0.000278	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—HMOX1—atherosclerosis	7.95e-05	0.00027	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—NOS2—atherosclerosis	7.81e-05	0.000265	CbGpPWpGaD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	7.65e-05	0.00026	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—APOB—atherosclerosis	7.61e-05	0.000258	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	7.44e-05	0.000253	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GSTM1—atherosclerosis	7.4e-05	0.000251	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—LPL—atherosclerosis	7.27e-05	0.000247	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GPX1—atherosclerosis	7.09e-05	0.000241	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	7.07e-05	0.00024	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	6.97e-05	0.000237	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CD36—atherosclerosis	6.91e-05	0.000234	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—atherosclerosis	6.58e-05	0.000223	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—MTHFR—atherosclerosis	6.54e-05	0.000222	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	6.53e-05	0.000222	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	6.44e-05	0.000219	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PPARA—atherosclerosis	6.42e-05	0.000218	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—AGT—atherosclerosis	6.22e-05	0.000211	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	6.1e-05	0.000207	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—APOE—atherosclerosis	6.09e-05	0.000207	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CAV1—atherosclerosis	6.04e-05	0.000205	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—APOA1—atherosclerosis	6.02e-05	0.000204	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	5.85e-05	0.000198	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	5.64e-05	0.000191	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PIK3CG—atherosclerosis	5.5e-05	0.000187	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PPARG—atherosclerosis	5.31e-05	0.00018	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—INS—atherosclerosis	5.2e-05	0.000177	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IFNG—atherosclerosis	5.19e-05	0.000176	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CXCL8—atherosclerosis	4.83e-05	0.000164	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ALB—atherosclerosis	4.77e-05	0.000162	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL1B—atherosclerosis	4.63e-05	0.000157	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	4.62e-05	0.000157	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—NOS3—atherosclerosis	4.56e-05	0.000155	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	4.54e-05	0.000154	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—atherosclerosis	4.53e-05	0.000154	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	4.19e-05	0.000142	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PTGS2—atherosclerosis	4.17e-05	0.000142	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	4.05e-05	0.000137	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—VEGFA—atherosclerosis	3.92e-05	0.000133	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	3.77e-05	0.000128	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	3.63e-05	0.000123	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—TGFB1—atherosclerosis	3.6e-05	0.000122	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	3.42e-05	0.000116	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—TNF—atherosclerosis	3.36e-05	0.000114	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—LDLRAP1—atherosclerosis	3.36e-05	0.000114	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PLTP—atherosclerosis	3.16e-05	0.000107	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	2.96e-05	0.0001	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	2.92e-05	9.9e-05	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	2.89e-05	9.8e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	2.88e-05	9.77e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ABCG8—atherosclerosis	2.74e-05	9.29e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—LTA4H—atherosclerosis	2.74e-05	9.29e-05	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	2.68e-05	9.11e-05	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	2.46e-05	8.33e-05	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	2.37e-05	8.03e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ABCG1—atherosclerosis	2.16e-05	7.34e-05	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	2.13e-05	7.23e-05	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—AKT1—atherosclerosis	2.1e-05	7.12e-05	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	2.09e-05	7.11e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2.07e-05	7.02e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—FABP4—atherosclerosis	2.03e-05	6.9e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—LCAT—atherosclerosis	2.03e-05	6.9e-05	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	2.01e-05	6.83e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—APOA4—atherosclerosis	2e-05	6.78e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP7A1—atherosclerosis	1.96e-05	6.66e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PLTP—atherosclerosis	1.95e-05	6.6e-05	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	1.93e-05	6.56e-05	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.86e-05	6.3e-05	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1.83e-05	6.21e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP27A1—atherosclerosis	1.81e-05	6.15e-05	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	1.78e-05	6.03e-05	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.78e-05	6.02e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ALOX15—atherosclerosis	1.72e-05	5.83e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ALOX5AP—atherosclerosis	1.72e-05	5.83e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.72e-05	5.83e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—APOA2—atherosclerosis	1.72e-05	5.83e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ABCG5—atherosclerosis	1.7e-05	5.76e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.69e-05	5.72e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.69e-05	5.72e-05	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.66e-05	5.63e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—LPA—atherosclerosis	1.64e-05	5.57e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—BGN—atherosclerosis	1.59e-05	5.39e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—APOA5—atherosclerosis	1.57e-05	5.34e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.51e-05	5.14e-05	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.5e-05	5.09e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ALOX5—atherosclerosis	1.46e-05	4.96e-05	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.41e-05	4.77e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.33e-05	4.52e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NAMPT—atherosclerosis	1.31e-05	4.45e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—LIPC—atherosclerosis	1.3e-05	4.42e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—APOC3—atherosclerosis	1.29e-05	4.39e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—LDLR—atherosclerosis	1.29e-05	4.37e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CETP—atherosclerosis	1.26e-05	4.27e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—FABP4—atherosclerosis	1.25e-05	4.25e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—LCAT—atherosclerosis	1.25e-05	4.25e-05	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.23e-05	4.19e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—APOA4—atherosclerosis	1.23e-05	4.18e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.21e-05	4.1e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SCARB1—atherosclerosis	1.2e-05	4.09e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HMGCR—atherosclerosis	1.14e-05	3.86e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.12e-05	3.79e-05	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.11e-05	3.78e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.06e-05	3.59e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.06e-05	3.59e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.06e-05	3.59e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—APOA2—atherosclerosis	1.06e-05	3.59e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.05e-05	3.55e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ABCA1—atherosclerosis	1.01e-05	3.44e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—LPA—atherosclerosis	1.01e-05	3.43e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—BGN—atherosclerosis	9.79e-06	3.32e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—APOA5—atherosclerosis	9.69e-06	3.29e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	9.33e-06	3.16e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ALOX5—atherosclerosis	9.01e-06	3.06e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HMOX1—atherosclerosis	8.69e-06	2.95e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—APOB—atherosclerosis	8.33e-06	2.83e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTM1—atherosclerosis	8.1e-06	2.75e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NAMPT—atherosclerosis	8.08e-06	2.74e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—LIPC—atherosclerosis	8.03e-06	2.72e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—APOC3—atherosclerosis	7.98e-06	2.71e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—LPL—atherosclerosis	7.95e-06	2.7e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—LDLR—atherosclerosis	7.93e-06	2.69e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GPX1—atherosclerosis	7.76e-06	2.63e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CETP—atherosclerosis	7.74e-06	2.63e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CD36—atherosclerosis	7.55e-06	2.56e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SCARB1—atherosclerosis	7.42e-06	2.52e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—MTHFR—atherosclerosis	7.16e-06	2.43e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PPARA—atherosclerosis	7.02e-06	2.38e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HMGCR—atherosclerosis	7e-06	2.38e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—AGT—atherosclerosis	6.8e-06	2.31e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—APOE—atherosclerosis	6.66e-06	2.26e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CAV1—atherosclerosis	6.6e-06	2.24e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—APOA1—atherosclerosis	6.59e-06	2.24e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ABCA1—atherosclerosis	6.24e-06	2.12e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PIK3CG—atherosclerosis	6.01e-06	2.04e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PPARG—atherosclerosis	5.81e-06	1.97e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—INS—atherosclerosis	5.69e-06	1.93e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.36e-06	1.82e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ALB—atherosclerosis	5.22e-06	1.77e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—APOB—atherosclerosis	5.13e-06	1.74e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NOS3—atherosclerosis	4.99e-06	1.69e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.99e-06	1.69e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—LPL—atherosclerosis	4.9e-06	1.66e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GPX1—atherosclerosis	4.78e-06	1.62e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CD36—atherosclerosis	4.65e-06	1.58e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PTGS2—atherosclerosis	4.57e-06	1.55e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.41e-06	1.5e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PPARA—atherosclerosis	4.33e-06	1.47e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—AGT—atherosclerosis	4.19e-06	1.42e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—APOE—atherosclerosis	4.11e-06	1.39e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CAV1—atherosclerosis	4.07e-06	1.38e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—APOA1—atherosclerosis	4.06e-06	1.38e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.71e-06	1.26e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PPARG—atherosclerosis	3.58e-06	1.21e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—INS—atherosclerosis	3.51e-06	1.19e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ALB—atherosclerosis	3.22e-06	1.09e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NOS3—atherosclerosis	3.08e-06	1.04e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.81e-06	9.55e-06	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—AKT1—atherosclerosis	2.3e-06	7.79e-06	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—AKT1—atherosclerosis	1.41e-06	4.8e-06	CbGpPWpGaD
